Astrana Health Forecast, price target & analysts
Astrana Health Target price 2025 - Analyst rating & recommendation
Astrana Health Classifications & Recommendation:
Astrana Health Price Target
| Target Price | $50.45 |
| Price | $30.34 |
| Potential |
66.30%
register free of charge
|
| Number of Estimates | 11 |
|
11 Analysts have issued a price target Astrana Health 2026 .
The average Astrana Health target price is $50.45.
This is
66.30%
register free of charge
$70.00
130.72%
register free of charge
$36.00
18.66%
register free of charge
|
|
| A rating was issued by 13 analysts: 10 Analysts recommend Astrana Health to buy, 3 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Astrana Health stock has an average upside potential 2026 of
66.30%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 2.03 | 2.63 |
| 46.72% | 29.38% | |
| EBITDA Margin | 5.76% | 7.07% |
| 21.91% | 22.65% | |
| Net Margin | 2.12% | 2.34% |
| 52.45% | 10.37% |
10 Analysts have issued a sales forecast Astrana Health 2025 . The average Astrana Health sales estimate is
This results in the following potential growth metrics:
12 Analysts have issued an Astrana Health EBITDA forecast 2025. The average Astrana Health EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
12 Astrana Health Analysts have issued a net profit forecast 2025. The average Astrana Health net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 0.90 | 1.29 |
| 30.23% | 43.33% | |
| P/E | 23.58 | |
| EV/Sales | 0.57 |
12 Analysts have issued a Astrana Health forecast for earnings per share. The average Astrana Health EPS is
This results in the following potential growth metrics and future valuations:
Current Astrana Health Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Barclays |
Locked
➜
Locked
|
Locked | Apr 01 2025 |
| Truist Securities |
Locked
➜
Locked
|
Locked | Mar 18 2025 |
| B of A Securities |
Locked
➜
Locked
|
Locked | Mar 04 2025 |
| Baird |
Locked
➜
Locked
|
Locked | Mar 03 2025 |
| Stifel |
Locked
➜
Locked
|
Locked | Feb 20 2025 |
| Truist Securities |
Locked
➜
Locked
|
Locked | Jan 13 2025 |
| Baird |
Locked
➜
Locked
|
Locked | Nov 13 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
Barclays:
Locked
➜
Locked
|
Apr 01 2025 |
|
Locked
Truist Securities:
Locked
➜
Locked
|
Mar 18 2025 |
|
Locked
B of A Securities:
Locked
➜
Locked
|
Mar 04 2025 |
|
Locked
Baird:
Locked
➜
Locked
|
Mar 03 2025 |
|
Locked
Stifel:
Locked
➜
Locked
|
Feb 20 2025 |
|
Locked
Truist Securities:
Locked
➜
Locked
|
Jan 13 2025 |
|
Locked
Baird:
Locked
➜
Locked
|
Nov 13 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
